Holen Sie sich die Stockscreener-App
17.83
0.73%
0.13
Schlusskurs vom Vortag:
$17.70
Offen:
$17.72
24-Stunden-Volumen:
285.48K
Relative Volume:
0.44
Marktkapitalisierung:
$1.90B
Einnahmen:
Nettoeinkommen (Verlust:
KGV:
-
EPS:
-
Netto-Cashflow:
1W Leistung:
+0.88%
1M Leistung:
-30.22%
6M Leistung:
-30.22%
1J Leistung:
-30.22%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$17.06
$18.82
52-Wochen-Spanne:
$16.07
$25.55
ADARx Pharmaceuticals, Inc. Common Stock Stock (ADRX) Company Profile
Firmenname
ADARx Pharmaceuticals, Inc. Common Stock
Sektor
Branche
Telefon
-
Adresse
-
Compare ADRX vs VRTX, MRNA, REGN, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADRX
ADARx Pharmaceuticals, Inc. Common Stock
|
17.83 | 1.90B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
498.50 | 126.35B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
226.30 | 90.35B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
778.36 | 80.14B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
818.30 | 51.46B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
193.52 | 41.48B | 742.00K | -1.37B | -1.07B | -7.0731 |
ADARx Pharmaceuticals, Inc. Common Stock Aktie (ADRX) Neueste Nachrichten
Simeon George Discloses Investment at ADARx Pharmaceuticals with 9.3% Stake - TradingView
ADRX News & Events - Intellectia AI
OrbiMed Advisors Discloses Investment at ADARx Pharmaceuticals with 14.0% Stake - TradingView
Upcoming & Recent IPO'sIPOs Calendar - ca.finance.yahoo.com
ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares Granted in Its Initial Public Offering - FinancialContent
Form 4 ADARx Pharmaceuticals For: 30 September By Investing.com - Investing.com South Africa
ADARx Pharmaceuticals Director Reports Preferred Stock Conversions and IPO Share Purchase - Kalkine Media
At $17 a share, OrbiMed Israel Partners II buys 61,516 IPO shares in ADARx Pharmaceuticals (ADRX). - Stock Titan
Options on 170,692 shares at $17 each go to ADARx Pharmaceuticals (ADRX) chief scientific officer. - Stock Titan
ADARx Raises $446.3 Million in IPO Priced at $17.00 Per Share - Minichart
Latham & Watkins Advises on ADARx Pharmaceuticals’ Upsized US$446.3 Million Initial Public Offering - Legal Desire
ADARx Pharmaceuticals Shares Jump On Nasdaq Debut - Yahoo Finance
Another top IPO: Adarx’s $446M to advance clinical siRNA assets - BioWorld News
Adarx Pharmaceuticals allocates 55% of IPO to 10 investors By Investing.com - Investing.com
Latham & Watkins Advises on ADARx Pharmaceuticals’ Upsized US$446.3 Million Initial Public Offering - Latham & Watkins LLP
Adarx Pharmaceuticals allocates 55% of IPO to 10 investors By Investing.com - Investing.com
ADARx Pharmaceuticals, Inc. Common Stock (ADRX) Income StatementYahoo Finance - Yahoo! Finance Canada
ADARx Pharmaceuticals Prices Upsized $446.3 Million Initial Public Offering - Yahoo Finance
ADARx raises $446M in biotech’s third largest IPO of 2026, City files to go public - BioSpace
Form S-1 ADARx Pharmaceuticals For: 25 September By Investing.com - Investing.com UK
Adarx Pharmaceuticals IPO opens at $22.10, 30% above pricing - scanx.trade
Articles from ADARx Pharmaceuticals Inc. - FinancialContent
IPO calendar for: - Yahoo Finance Singapore
IPO calendar for: - Yahoo Finance Singapore
ADARx Pharmaceuticals prices $446.3M IPO at $17 per share - Investing.com
ADARx Pharmaceuticals prices upsized IPO at $17 per share - Investing.com
ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering - Yahoo Finance
Total common shares outstanding of ADARx Pharmaceuticals, Inc. – NASDAQ:ADRX - tradingview.com
Diluted net income available to common stockholders of ADARx Pharmaceuticals Inc. – NASDAQ:ADRX - tradingview.com
ADARx Pharmaceuticals (ADRX): ADARx Sets Terms, Targets Up to $372m in IPO, AbbVie Alongside - Smartkarma
ADARx Pharmaceuticals Plans IPO of 21.9M Shares at $15-$17 Each - Yahoo Finance
ADARx Pharmaceuticals Seeks IPO On Strong Collaboration Deal With AbbVie (Pending:ADRX) - Seeking Alpha
Finanzdaten der ADARx Pharmaceuticals, Inc. Common Stock-Aktie (ADRX)
Es liegen keine Finanzdaten für ADARx Pharmaceuticals, Inc. Common Stock (ADRX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
ADARx Pharmaceuticals, Inc. Common Stock-Aktie (ADRX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| George Simeon | Director |
Sep 28 '26 |
Buy |
17.00 |
1,600,000 |
27,200,000 |
5,554,094 |
| GORDON CARL L | Director |
Sep 28 '26 |
Buy |
17.00 |
950,000 |
16,150,000 |
14,325,529 |
| ORBIMED ADVISORS LLC | Director |
Sep 28 '26 |
Buy |
17.00 |
950,000 |
16,150,000 |
14,325,529 |
| SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner |
Sep 28 '26 |
Buy |
17.00 |
1,600,000 |
27,200,000 |
5,554,094 |
1.20%
0.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):